These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34188210)

  • 61. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Information for patients. Pancreatic cancer].
    A-Cienfuegos J; Rotellar F
    Rev Esp Enferm Dig; 2012 Jul; 104(7):385. PubMed ID: 22849502
    [No Abstract]   [Full Text] [Related]  

  • 63. [Pancreatic tumours].
    Barbier L; Delpero JR
    Rev Prat; 2014 Nov; 64(9):1307-12. PubMed ID: 25638877
    [No Abstract]   [Full Text] [Related]  

  • 64. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
    Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
    Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
    Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
    Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Galectin-12 in Pancreatic Cancer: A New Player in the Microenvironment?
    Galdino LV; Albuquerque APB; Lira MMM; de Lima LRA; Pitta MGDR; Rêgo MJBM
    Pancreas; 2021 Oct; 50(9):e78-e79. PubMed ID: 34860822
    [No Abstract]   [Full Text] [Related]  

  • 67. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SnapShot: pancreatic cancer.
    Han H; Von Hoff DD
    Cancer Cell; 2013 Mar; 23(3):424-424.e1. PubMed ID: 23518352
    [No Abstract]   [Full Text] [Related]  

  • 69. Pathological and molecular evaluation of pancreatic neoplasms.
    Rishi A; Goggins M; Wood LD; Hruban RH
    Semin Oncol; 2015 Feb; 42(1):28-39. PubMed ID: 25726050
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
    Muckenhuber A; Berger AK; Schlitter AM; Steiger K; Konukiewitz B; Trumpp A; Eils R; Werner J; Friess H; Esposito I; Klöppel G; Ceyhan GO; Jesinghaus M; Denkert C; Bahra M; Stenzinger A; Sprick MR; Jäger D; Springfeld C; Weichert W
    Clin Cancer Res; 2018 Jan; 24(2):351-359. PubMed ID: 29101303
    [No Abstract]   [Full Text] [Related]  

  • 71. Cytoplasmic MUC1 in PanIN-1.
    Bara J; Forgue-Lafitte ME
    Clin Cancer Res; 2008 Aug; 14(16):5306; author reply 5306-7. PubMed ID: 18698052
    [No Abstract]   [Full Text] [Related]  

  • 72. Lessons learned from a complete remission of advanced metastatic pancreatic ductal adenocarcinoma.
    Mathew BM; Daas AY; Centeno BA; Hoffe S; Valone T; Patel M; Springett GM
    Clin Adv Hematol Oncol; 2012 May; 10(5):340-3. PubMed ID: 22706548
    [No Abstract]   [Full Text] [Related]  

  • 73. Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution.
    Gutiérrez ML; Sayagués JM; Abad Mdel M; Bengoechea O; González-González M; Orfao A; Muñoz-Bellvis L
    Histopathology; 2011 Feb; 58(3):486-97. PubMed ID: 21323969
    [No Abstract]   [Full Text] [Related]  

  • 74. Molecular biology of pancreatic ductal adenocarcinoma.
    Coleman SJ; Rhim AD
    Curr Opin Gastroenterol; 2014 Sep; 30(5):506-10. PubMed ID: 25023382
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A white paper: the product of a pancreas cancer think tank.
    Kern S; Hruban R; Hollingsworth MA; Brand R; Adrian TE; Jaffee E; Tempero MA
    Cancer Res; 2001 Jun; 61(12):4923-32. PubMed ID: 11406572
    [No Abstract]   [Full Text] [Related]  

  • 76. Challenging Topics in Pancreatic Neoplasia.
    Basturk O; Krasinskas AM
    Arch Pathol Lab Med; 2020 Jul; 144(7):806-807. PubMed ID: 33761530
    [No Abstract]   [Full Text] [Related]  

  • 77. [Mucin gene family and its role in diagnosis of pancreas neoplasms].
    Ji Y; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):113-6. PubMed ID: 16630488
    [No Abstract]   [Full Text] [Related]  

  • 78. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.
    Chen Y; Xie D; Yin Li W; Man Cheung C; Yao H; Chan CY; Chan CY; Xu FP; Liu YH; Sung JJ; Kung HF
    Cancer Lett; 2010 Nov; 297(1):109-16. PubMed ID: 20684863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
    Hidalgo M; Álvarez R; Gallego J; Guillén-Ponce C; Laquente B; Macarulla T; Muñoz A; Salgado M; Vera R; Adeva J; Alés I; Arévalo S; Blázquez J; Calsina A; Carmona A; de Madaria E; Díaz R; Díez L; Fernández T; de Paredes BG; Gallardo ME; González I; Hernando O; Jiménez P; López A; López C; López-Ríos F; Martín E; Martínez J; Martínez A; Montans J; Pazo R; Plaza JC; Peiró I; Reina JJ; Sanjuanbenito A; Yaya R; Carrato A
    Clin Transl Oncol; 2017 Jun; 19(6):667-681. PubMed ID: 27995549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
    Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.